炎症性细胞因子与肺功能,慢性肺病和COVID-19的关联
Marina O Rontogianni1, Dipender Gill2, Emmanouil Bouras1
1Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
iScience
|September 25, 2024
概括
这项研究探讨了35种炎症性细胞因子对COVID-19和喘等呼吸系统疾病的影响. 某些细胞因子,包括MCSF和sICAM,显示出作为肺部疾病治疗点的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
- 呼吸系统医学 呼吸系统医学
背景情况:
- 炎症性细胞因子在呼吸系统健康和疾病中发挥着关键作用.
- 了解细胞因子与COVID-19,喘和COPD等疾病的关联对于开发向疗法至关重要.
研究的目的:
- 研究35种炎症性细胞因子与各种呼吸系统结果之间的因果关系.
- 为了确定潜在的细胞因子为基础的治疗点呼吸系统疾病.
主要方法:
- 利用孟德尔的随机化和同地化分析来评估遗传关联.
- 在英国生物银行使用观察分析来验证新发现.
主要成果:
- 确定了巨菌群刺激因子 (MCSF),sICAM和sVCAM-1与COVID-19风险之间的反向关联.
- 发现sICAM与阿托皮性喘有积极的关联,而TNF-α显示了相反的关联.
- 介素-18与COPD风险增加有关,IL-1ra与改善肺功能有关,一些发现通过观察重复.
结论:
- 一些炎症性细胞因子,包括MCSF,sICAM,sVCAM-1,TNF-α,IL-18,IL-1ra和MCP-3,与呼吸系统结果有显著的关联.
- 这些细胞因子代表了治疗和预防呼吸系统疾病的有希望的药理学标.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Drugs Used in Lower Respiratory Disorders: Overview
360
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
360
COPD: Pathogenesis and Clinical Features
243
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
243


